The Use of Cyclokapron for Treatment and Management of Women With Bleeding Disorders
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The high percentage of failure using available non-surgical options to treat menorrhagia in
women with bleeding disorders shows a continuing need for innovative treatments. This has led
to development of this protocol in order to make available tranexamic acid as a potentially
effective menorrhagia therapy option in women with an underlying bleeding disorder. We
anticipate that Tranexamic Acid may be a beneficial choice for controlling menorrhagia in
bleeding disorder patients.